UNASSIGNED: Single nucleotide polymorphisms (SNPs) have the potential to improve personalized medicine in @entity0 care. As new SNPs are discovered, further enhancing risk classification, SNP testing may serve to complement family history and phenotypic risk factors when assessed in a clinical setting. SNP analysis is particularly relevant to high-risk @entity1 who may seek out such information to guide their decision-making around risk-reduction. However, little is known about how high-risk @entity1 may respond to SNP testing with regard to clinical decision-making. We examined high-risk @entity1 's interest in SNP testing for @entity0 risk through an online survey of hypothetical testing scenarios. @entity1 stated their preferences for sharing test results and selected the most likely follow-up action they would pursue in each of the test result scenarios (above average and below average risk for @entity0 ). Four hundred seventy-eight @entity1 participated. Most @entity1 (89  %) did not know what a SNP was prior to the study. Once SNP testing was described, 75  % were interested in SNP testing. @entity1 stated an interest in lifestyle interventions for risk-reduction and wanted to discuss their testing results with their doctor or a genetic counselor. @entity1 are interested in SNP testing and are prepared to make lifestyle changes based on testing results. @entity1 's preference for discussing testing results with a healthcare provider aligns with the current trend towards SNP testing in a clinical setting.

Personalized Medicine Through SNP Testing for XXXX Risk: Clinical Implementation.

@entity1 :: ('9606', 'Species') :: ['Participants', 'Women', 'women'] @entity0 :: ('MESH:D001943', 'Disease') :: ['breast cancer']
@entity0 :: (MESH:D001943,Disease) :: ['Breast Cancer']
